IMMX - Immix Biopharma, Inc.
2.09
-0.055 -2.632%
Share volume: 47,479
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$2.14
-0.06
-0.03%
Summary score
43%
Profitability
35%
Dept financing
36%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-21.45%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
32.02%
Debt ratio change over timeo
0%
Current Ratio
4.08%
Quick Ratio
0%
Cash Position Ratio
3.61%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-22.75%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
35.34%
Debt ratio change over timeo
0%
Current Ratio
3.65%
Quick Ratio
0%
Cash Position Ratio
3.22%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-23.54%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
51.77%
Debt ratio change over time
0%
Current Ratio
1.8%
Quick Ratio
0%
Cash Position Ratio
1.71%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMMX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -21.45% | 4.23% | 3.2% | 0% |
| Return on sales | 0% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 32.02% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 35% | 25% | 18% | 0% |
| Current Ratio | 3.65% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 3.22% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 32% | 36% | 0% |
| Short-term ratios | IMMX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -22.75% | 4.32% | 3.49% | 0% |
| Return on sales | 0% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 35.34% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 36% | 25% | 18% | 0% |
| Current Ratio | 3.65% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 3.22% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 34% | 35% | 0% |
